Universal Access and Affordable Medicines
About our work on access to medicines
Publications
EPHA Response to public consultation on EMA Regulatory Science to 2025
Getting it right: how to improve the European Commission proposal on HTA
Recommendations on a new model for the provision of scientific advice
Latest Developments
Protect open access to clinical study reports
EPHA joins calls to protect access to clinical trials data ahead of a forthcoming judgment from the European Court of Justice
read moreProtect the public interest in EU health research
EPHA joins calls for the Commission to protect the public interest in the development of the European Partnership on Innovative Health
read moreEPHA joins calls for a new approach for better medicines in Europe
EPHA joins calls for Treatment Optimization to become a standard step in the development of new medicines in the EU, putting patients at the heart of new developments in research and innovation
read moreAnalysis & Opinion
EU Review of Pharmaceutical Incentives – An Opportunity for Change
Ellen ‘t Hoen of Medicines Law and Policy on why it is time to change the system of pharmaceutical incentives in the EU
read moreMedicines shortages – the new cancer of Europe
Calls are growing for concerted EU action to tackle medicines shortages across Europe.
read moreSustainable Innovation in Treatment Development: Re-engineering the Process for Access
Denis Lacombe, Director General, European Organisation for Research and Treatment of Cancer asks how can we ensure the needs of patients remain central as new treatments are developed?
read moreEvents
Time for a new deal
14 November 20194th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Past events
Putting health first
3 June 2019Trailblazers, routes to better and affordable medicines by 2025
20 November 2018How good are our medicines?
3 October 2018Game changers for better and affordable medicines in Europe
21 November 2017Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
Yannis Natsis
Policy Manager
yannis@epha.org
+32 2 233 3886